Search research articles
Contact Us
Filters
Showing results (91-100 of 94) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 94 results.
JAMA Psychiatry
|
August 3, 2017
The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial
David H Barlow, Todd J Farchione, Jacqueline R Bullis, et al.
Stroke
|
December 6, 2014
Computed tomography identifies patients at high risk for stroke after transient ischemic attack/nondisabling stroke: prospective, multicenter cohort study
Jason K Wasserman, Jeffrey J Perry, Marco L A Sivilotti, et al.
ESC Heart Failure
|
December 7, 2020
Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
Nicholas J Viney, Shuling Guo, Li-Jung Tai, et al.
Science Translational Medicine
|
May 14, 2025
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy
Beltran Borges, Stephen M Brown, Wan-Jin Chen, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 94) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 94 results.
JAMA Psychiatry
|
August 3, 2017
The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial
David H Barlow, Todd J Farchione, Jacqueline R Bullis, et al.
Stroke
|
December 6, 2014
Computed tomography identifies patients at high risk for stroke after transient ischemic attack/nondisabling stroke: prospective, multicenter cohort study
Jason K Wasserman, Jeffrey J Perry, Marco L A Sivilotti, et al.
ESC Heart Failure
|
December 7, 2020
Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
Nicholas J Viney, Shuling Guo, Li-Jung Tai, et al.
Science Translational Medicine
|
May 14, 2025
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy
Beltran Borges, Stephen M Brown, Wan-Jin Chen, et al.
Page
of 10